Pharmalot… Pharmalittle… Good Morning

Top of the morning to you. And a fine one it is, if a bit cold. But it is wintertime, so we are not surprised. Another thing that is unsurprising is the amount of goings-on now that the new year has sprung. So to celebrate – and to cope – we are brewing a delicious cup of stimulation and invite you to join us. After all, this may help tackle that to-do list. Meanwhile, here are some tidbits. Have a grand day and stay in touch… Merck CEO Sees More Consolidation (Wall Street Journal) Novartis Wins UK NICE OK For Lucentis After Price Cut (Bloomberg News) Merck Resubmits Combo Cholesterol Pill To FDA (Associated Press) Amgen Whistleblower Loses Bid To Challenge Aranesp Deal (Bloomberg News) Synergy Reports Positive Results For Constipation Drug (Reuters) Shortages Linked To Relapses In Hodgkin Lymphoma Patients (Pharma Times) Bayer’s Nexavar Meets Goal In Thyroid Cancer Trial (Reuters) Salix Wins FDA Approval For Diarrhea Drug (Associated Press) AbbVie To Add 175 Jobs In Ireland (Irish Examiner) EDITOR’S NOTE: Please check this post for updates kettle pic thx to mirahartford on flickr
Source: Pharmalot - Category: Pharma Commentators Authors: Tags: Uncategorized Abbvie ALS Amgen Aranesp Bayer Biogen Cholseterol Drug Shortages Lucentis Merck Novartis Salix Pharmacuetical Synergy Pharmaceutical Whistleblower Source Type: blogs

Related Links:

Publication date: Available online 13 November 2019Source: Journal of Photochemistry and Photobiology B: BiologyAuthor(s): Pandiyan Nithya, Murugesan Balaji, Arumugam Mayakrishnan, Chinnalagu Dhilip Kumar, Selvaraj Rajesh, Azhagar Surya, Mahalingam SundrarajanAbstractThe noble metal such as Ag and Au doped CeO2 nanoparticles was successfully prepared by ionic liquid assisted hydrothermal method in the presence of Justicia adhatoda leaves extract and were used as an antibacterial and anticancer agent. The FT-IR and Raman spectrum exhibit the peaks at 460 and 464 cm−1 assigned to CeO stretching vibrations of NPs. The...
Source: Journal of Photochemistry and Photobiology B: Biology - Category: Speech-Language Pathology Source Type: research
Abstract Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer type globally and contributes significantly to burden of disease in South Asia. In Pakistan, HNSCC is among the most commonly diagnosed cancer in males and females. The increasing regional burden of HNSCC along with a unique set of risk factors merited a deeper investigation of the disease at the genomic level. Whole exome sequencing of HNSCC samples and matched normal genomic DNA analysis (n=7) was performed. Significant somatic single nucleotide variants (SNVs) were identified and pathway analysis performed to determine frequently affe...
Source: Genetics and Molecular Biology - Category: Genetics & Stem Cells Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): C. Van Der Fels, S. Palthe, M.C. Van Den Heuvel, I.J. De Jong
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): R. Bientinesi, V. Di Paola, R. Manfredi, P. Bassi
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): X. Yu, G. Fan
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): L. Lopez, J. Rivière, G. Pierquet, J. Piéchaud-Kressmann, J-L. Hoepffner, J-B. Roche, R. Gaston, J. Rouffilange, T. Piéchaud
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): R. Rodrigues Fonseca, R. Lains Mota, I. Peyroteo, A. Bilé Silva, J.C. Santos, F. Alpoim Lopes, A. Covita, A. Canhoto, P. Monteiro, R. Nogueira, L. Abranches Monteiro
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): H. Yaegashi, S. Kadomoto, R. Naito, T. Makino, H. Iwamoto, T. Nohara, K. Shigehara, K. Izumi, Y. Kadono, E. Mizuno, A. Mizokami
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): D. Meijer, B.H.E. Jansen, M. Wondergem, S. Srbljin, A.E. Vellekoop, A. Keizer, O.S. Hoekstra, J.A. Nieuwenhuijzen, D.E. Oprea-Lager, A.N. Vis
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 10Author(s): B.H.E. Jansen, M. Wondergem, F.M. Van Der Zant, T.M. Van Der Sluis, R.J.J. Knol, L.W.M. Van Kalmthout, O. Hoekstra, R.J.A. Van Moorselaar, D.E. Oprea-Lager, A.N. Vis
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research
More News: Aranesp | Cancer | Cancer & Oncology | Cholesterol | Constipation | Ireland Health | Jobs | Lucentis | Lymphoma | Merck | National Institute for Health and Clinical Excelle | Pharma Commentators | Pharmaceuticals | Ranibizumab Injection | Thyroid | Thyroid Cancer